趙 庭興

研究成果

每年研究成果 1996 2000 2003 2016 2022 2023

• 120 Article
• 9 Review article
• 2 Letter
• 1 Comment/debate

每年研究成果

每年研究成果

搜尋結果

• 2018

  Erratum: ‘Corrigendum to “2017 Taiwan lipid guidelines for high risk patients” [Journal of the Formosan Medical Association (2017) [217–248]’(S0929664616304302)(10.1016/j.jfma.2016.11.013)

  The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients, 2018 8月, 於: Journal of the Formosan Medical Association. 117, 8, p. 749-750 2 p.

  研究成果: Comment/debate › 同行評審

  • evolocumab 84%
  • Lipids 66%
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors 65%
  • Guidelines 65%
  • alirocumab 56%
  1 引文 斯高帕斯（Scopus）